Results

Total Results: 723 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

241. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - advantage of the incident user design is that it can capture the clinical consequences of an entire therapeutic … and risk of complications in patients with type 2 diabetes (UKPDS 33). … Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled … Structural accelerated failure time models for survival analysis in studies with time- varying treatments … A review of uses of health care utilization databases for epidemiologic research on therapeutics.

242. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
     October 01, 2021 - ), revascularization, composite cardiovascular outcomes, withdrawal due to adverse events, cancer, diabetes … 21313 2666 20491 0.99 0.94 1.04 0 High Cancer 10 1181 27759 1174 27795 1.02 0.90 1.16 0.43 High Diabetes … group trt_N Total N of treatment group ctrl_n Number of events in control group ctrl_N Total N of … group ctrl_bl_mean Weighted mean at baseline of treatment group trt_N Total N of treatment group … Opioid Treatments for Chronic Pain.

243. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - RESULTS The cohort consisted of 15,389 new users of APMs of which 4905 initiated conventional APM therapy … However, if physicians who frequently pre- scribe atypical APMs were using more hazardous treatments, … �80 10,750 70.0 History of Cerebrovascular disease 4661 30.3 Congestive heart failure 4918 32.0 Diabetes … History of Cerebrovascular disease 1.9 0.04 0.5 0.54 Congestive heart failure �1.2 0.22 �0.9 0.26 Diabetes … analysis and external adjustment for unmea- sured confounders in epidemiologic database studies of therapeutics

244. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
     November 16, 2010 - at this asymptomatic or early stage improves important health outcomes more than treatment once an … older age, and specific ocular or other medical conditions as defined by included studies (e.g., diabetes … Secondary outcome: We will also compare visual acuity outcomes (as measured by the Early Treatment … In general, the figure illustrates how screening-based programs (which may incorporate treatment when … Measures of treatment effect We will calculate summary risk ratios or odds ratios as appropriate for

245. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
     May 01, 2025 - First, regarding “drug holidays” (i.e. pausing antiresorptive therapy before and after dental treatments … Treatment strategies were outlined for non-operative therapies and operative treatments in clinical … SIPMO-SICMF recognized use of systemic antibiotic therapy in treatment of MRONJ-related infections and … Diabetes as a Risk Factor for Medication-Related Osteonecrosis of the Jaw. … Managing the Care of Patients Receiving Antiresorptive Therapy for Prevention and Treatment of Osteoporosis

246. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Every month since the CER’s original release, we received any FDA updates on the included treatments … to the conclusions involve refinement of original estimates or do the potential changes mean some therapies … * adj3 herb$2) or (therapeutic* adj3 plant$1) or (therapeutic* adj3 botanical*) or (plant$1 adj3 pharmacotherap … Inclusion criteria: diabetes or hypercholesterolemia under statin treatment, and at least 1 of the … Vitamin K may improve the stability of anticoagulant therapy.

247. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research

248. Frameworks for Determining Research Gaps During Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
     June 01, 2011 - of treatments, etc. … and “How should physicians choose an airway clearance therapy for a given patient with cystic fibrosis … Diabetes education for children with type 1 diabetes mellitus and their families. … of treatments, etc. … and “How should physicians choose an airway clearance therapy for a given patient with cystic fibrosis

249. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
     March 01, 2017 - Hormone Therapy Interventions • Hormone therapy shows mixed results of harm and benefit. • Low-strength … Antidementia Treatments • Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … Diabetes Medication Treatment • No studies reported on the effect of diabetes treatment on the risk … • We found no relevant studies for depression treatments, smoking cessation, or community-level interventions … Moderate-strength evidence showing no benefit for some antihypertensive treatments and vitamin E for

250. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
     March 01, 2017 - Hormone Therapy Interventions • Hormone therapy shows mixed results of harm and benefit. • Low-strength … Antidementia Treatments • Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … Diabetes Medication Treatment • No studies reported on the effect of diabetes treatment on the risk … • We found no relevant studies for depression treatments, smoking cessation, or community-level interventions … Moderate-strength evidence showing no benefit for some antihypertensive treatments and vitamin E for

251. FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
     May 01, 2013 - Often, standard medical therapies have failed these patients. … Most patients with chronic constipation have improvement of symptoms with medical therapy and/or lifestyle … Little data is available to support the timing of WMC in the diagnostic and therapeutic approach to … Currently, symptoms and symptom resolution guide therapeutic decisions, but these require careful interpretation … WMC in colonic dysmotility to predict outcomes, or to predict the effects medical and/or surgical therapy

252. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
     May 22, 2012 - clinical factors (such as age, existence of congestive heart failure or left ventricular dysfunction, diabetes … enlarged left atrium  Patients at high risk for stroke and bleeding events (e.g., patients with diabetes … with an enlarged left atrium o Patients at high risk for stroke and bleeding events (patients with diabetes … Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized … clinical factors (such as age, existence of congestive heart failure or left ventricular dysfunction, diabetes

253. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - Alternative Treatments Comparison of a treatment with a clinically meaningful alternative treatment … and glitazones for diabetes, and are not commonly used off-label for other conditions, the indication … analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics … Hormone replacement therapy and cardiovascular health in the United States. Med Care. … Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor a therapies

254. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
     June 15, 2016 - (including self-initiated therapies), and treatment duration or intensity? … (including self-initiated therapies), and treatment duration or intensity? … o Physical treatments and/or weight loss § Physical therapy and exercise programs • Manual therapy … Stem cell therapy trials will not have high applicability as this treatment is currently limited in … Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

255. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - similar across interventions used to treat a given condition (e.g., medications, non-pharmacological therapies … Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes … Title EPC, Year Condition/ Population Harms Related Key Question(s) Interventions Harms Outcomes Therapies … Dual agent therapy (statin + lipid modifying medication) and intensification of statin therapy … Graded Exercise Treatment; pharmaceutical; counseling/behavioral therapy; complimentary alternative

256. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - with antidepressants and other therapies, treatment is often augmented with antipsychotics.26" Substance … therapy?!! ! ! ! … therapy,!as!reported)_!medication!dose.!! Comparators! Placebo/no!treatment,!any!other! … diabetes! New6onset!diabetes,!exacerbation!of!previous!diabetes,!diabetic!ketoacidosis,! metabolic! … Indirect and mixed-treatment comparison, network, or multiple-treatments meta- analysis: many names,

257. Crosscutting Hi Impact (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … of chronic diseases requiring ongoing medication such as tuberculosis, diabetes, heart failure, and … Adherence to long-term therapies.

258. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Potential to change current treatment models ii. … The MarketScan Treatment Pathways data analytics tool was used to estimate costs of existing treatments … Process Off-Label Use Diabetes Technology & Therapeutics 1, 4, 5, 7 Monthly journal that publishes … treatments. … Process Off- Label Uses 1 Advanced Technologies & Treatments for Diabetes (ATTD) 1, 11 Annual

259. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Potential to change current treatment models ii. … The MarketScan Treatment Pathways data analytics tool was used to estimate costs of existing treatments … Process Off-Label Use Diabetes Technology & Therapeutics 1, 4, 5, 7 Monthly journal that publishes … treatments. … Process Off- Label Uses 1 Advanced Technologies & Treatments for Diabetes (ATTD) 1, 11 Annual

260. Data Points 17: Trends in Bariatric Surgery: Trends in bariatric surgery in Medicare beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery-trends_research.pdf
     November 01, 2012 - addition, studies have demonstrated significant improve- ments in medical comorbidities such as type 2 diabetes … or greater and at least one obesity-related comorbidity who have documented unsuc- cessful medical treatment … Reduction in incidence of diabetes, hyper- tension and lipid disturbances after intentional weight loss … CMS decision memo for bariatric surgery for the treatment of morbid obesity (CAG-00250R). 2006. … Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient